Skip to content

EBIT at other companies

Merit Medical Systems logo
Merit Medical SystemsMMSI
$44.16M+7.6%
ICU Medical logo
ICU MedicalICUI
$13.58M+5.4%
ITG
Integer HoldingsITGR
$31.87M-35.7%
Lumexa Imaging Holdings, Inc.
 logo
Lumexa Imaging Holdings, Inc. LMRI
$19.41M-24.0%
RadNet logo
RadNetRDNT
-$23.9M+0.8%
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC

Other financials

Income statement

See full
Revenue$22.0M+12.6%
Gross profit$16.8M+13.3%
Operating income$7.2M+33.2%
Net income$5.8M+24.1%
EPS (diluted)$0.45+21.6%

Balance sheet

See full
Cash & equivalents$56.4M+12.0%
Total debt$59.2K-96.9%
Total equity$98.5M+9.4%
Total assets$114.4M+12.4%

Cash flow

See full
Operating cash flow$8.3M+93.2%
CapEx$403.0K-89.1%
Free cash flow$7.9M+1,226%

Valuation

See full
Market cap$1.21B+63.4%
P/E51.3×+13.8×
P/S14×+4.2×

Profitability

See full
Gross margin76.8%-0.1pp
Operating margin32.4%+2.3pp
Net margin27.4%+1.0pp
FCF margin28.4%+8.9pp

Returns & leverage

See full
Return on equity25%+1.2pp
Debt / equity0.0×
Current ratio7.1×-1.7×

Where this comes from

Calculated from iRadimed’s reported figures.

Plus components not separately reported this period.

The official record: iRadimed’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about iRadimed's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is iRadimed's EBIT?
iRadimed (IRMD) reported EBIT of $7.24M in Q1 2026.
How has iRadimed's EBIT changed year-over-year?
iRadimed's EBIT increased by 33.2% year-over-year, from $5.43M to $7.24M.
What is the long-term trend for iRadimed's EBIT?
Over 4 years (2021 to 2025), iRadimed's EBIT has grown at a 27.7% compound annual growth rate (CAGR), from $9.82M to $26.15M.
What does EBIT mean?
Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.